Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Cabometyx is the third liver cancer drug approved in the past six months.
Rick George credits his spiritual life with seeing him through multiple health crises, including liver cancer.
A new study examines the clinical and economic impact of new direct-acting antivirals.
Liver cancer rates and deaths have doubled in the United States, Canada, Australia and United Kingdom.
Advocacy organizations are “alarmed” by the findings.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
Hepatitis B and C are declining as causes of liver cancer and liver transplants.
In the past, he was accused of misusing data, showing religious bias and discriminating against gay men and people with HIV.
Those who smoke and have liver cancer but not viral hepatitis did not have such an elevated risk.
Any previous apparent link between direct-acting antivirals, compared with interferon, and liver cancer was likely driven by other factors.
However, no such difference was seen among those with cirrhosis or those whose virus was not well treated.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.